Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
and S6 phosphorylation
which may result in the inhibition of cellular division and proliferation in tumor cells that overexpress AKs
22S)-16-acetyl-11-ethyl-12
RN-1 exhibits good brain penetration and retention
Ricietto AP
GZD824 - CAS# 1257628-77-5 ne Protease inhibitor Hydrochloride and S6 phosphorylationOlverembatinib, also known as GZD824, is a novel orally bioavailable inhibitor against a broad spectrum of Bcr Abl mutants including T315I. GZD824 tightly bound to Bcr Abl(WT) and Bcr Abl(T315I) with K(d) values of 0. 32 and 0. 71 nM, respectively, and strongly inhibited the kinase functions with nanomolar IC(50) values. GZD824 potently suppressed proliferation of Bcr Abl positive K562 and Ku812 human CML cells with IC(50) values of 0. 2 and 0. 13 nM,
US$ 119.00
US$ 1536.50
US$ 122.50
US$ 100.00
US$ 507.00
US$ 125.00
US$ 100.00
US$ 96.00
US$ 120.00
US$ 120.00